Paid Clinical Trials for Glioma

Showing 1 – 20 of 34 results

HER2-specific CAR T Cell Locoregional Immunotherapy for HER2-positive Recurrent/Refractory Pediatric CNS Tumors

by CTG

in Medulloblastoma, Glioma, Ependymoma, Germ Cell Tumor, Central Nervous System Tumor, Pediatric

Other

Washington

Deadline:

07/26/2039

Simultaneous Multinuclear Metabolic MRI in Newly Diagnosed or Recurrent Glioma

by CTG

in Glioma, Recurrent Malignant Glioma, Malignant Glioma, Recurrent Glioma

Other

California

Deadline:

09/10/2027

Superselective Intra-arterial Cerebral Infusion of Temsirolimus in HGG

by CTG

in Glioblastoma, Glioma, Glioma, Malignant, High Grade Glioma

Other

Arizona

Deadline:

05/01/2028

Abemaciclib Neuropharmacokinetics of Diffuse Midline Glioma Using Intratumoral Microdialysis

by CTG

in Glioma

Other

Maryland

Deadline:

09/01/2027

Hypofractionation Trial of Re-irradiation in Good Prognosis Recurrent Glioblastoma

by CTG

in Glioma, Astrocytoma, Recurrent Glioblastoma

Other

Maryland

Deadline:

12/31/2027

A Study Comparing Abemaciclib Plus Temozolomide to Temozolomide Monotherapy in Children and Young Adults With High-grade Glioma Following Radiotherapy

by CTG

in Glioma

Other

Alabama

Deadline:

02/01/2028

Cognitive Changes of IDH-mutant and IDH-wildtype Glioma Patients After Chemoradiotherapy With Radiation Dose to the Resting State Networks

by CTG

in Glioma

Other

Missouri

Deadline:

10/31/2033

Engineered HSV-1 M032 for the Treatment of Children and Adults With Newly Diagnosed Diffuse Midline Glioma After Standard of Care Radiation

by CTG

in Glioma

Other

Texas

Deadline:

12/31/2031

Methimazole in Patients With Progressive Glioblastoma

by CTG

in Glioblastoma, Glioma

Other

Ohio

Deadline:

07/01/2026

Evaluation of Hippocampal-Avoidance Using Proton Therapy in Low-Grade Glioma

by CTG

in Glioma, Pilocytic Astrocytoma, Pilomyxoid Astrocytoma, Pleomorphic Xanthoastrocytoma, Ganglioglioma

Other

Minnesota

Deadline:

07/01/2028

A Study to Learn About the Study Medicine Called PF-07799544 as Monotherapy or in Combination in People With Advanced Solid Tumors

by CTG

in Thyroid Cancer, Glioma, Non-small Cell Lung Cancer, Melanoma, Malignant Neoplasms

Other

Alabama

Deadline:

10/07/2028

Development of MRF for Characterization of Brain Tumors After Radiotherapy

by CTG

in Brain Metastases, Glioma, Brain Tumor, Brain Necrosis

Other

Ohio

Deadline:

06/01/2026

Step Count Monitoring as a Measure of Physical Activity in Patients With Newly Diagnosed Glioma Undergoing Radiation Therapy

by CTG

in Glioma, Radiation Therapy Patient

Other

Texas

Deadline:

12/31/2027

LITT Followed by Hypofractionated RT for Newly Diagnosed Gliomas (GCC 20138)

by CTG

in Glioblastoma, Glioma, Brain Tumor

Other

Maryland

Deadline:

12/01/2027

PrOton Pulsed reduCed dOse Rate Radiotherapy for Recurrent CNS maligNancies Trial

by CTG

in Glioma, Glioma, Malignant, Recurrent Glioma

Other

Florida

Deadline:

06/01/2029

Feasibility of Intraoperative Microdialysis During Neurosurgery for Central Nervous System Malignancies

by CTG

in Glioblastoma, Glioma, Metastatic Malignant Neoplasm in the Brain

Other

Minnesota

Deadline:

09/01/2027

A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations.

by CTG

in Thyroid Cancer, Glioma, Melanoma, Non-Small-Cell Lung Cancer, Advanced Colorectal Cancer (Part 1)

Other

Arkansas

Deadline:

04/05/2030

Simulation-Based Caregiving Skills Training for Family Members of High Grade Glioma Patients

by CTG

in Glioma

Other

Texas

Deadline:

08/31/2026

Tumor Treating Fields for the Treatment of Brainstem Gliomas

by CTG

in Glioma

Other

Georgia

Deadline:

05/01/2027

Safusidenib Phase 2 Study in IDH1 Mutant Glioma

by CTG

in Glioma, Astrocytoma, Grade IV, IDH1-mutant Glioma, Astrocytoma, IDH-Mutant, Grade 3, Astrocytoma, IDH-Mutant, Grade 4

Other

Alabama

Deadline:

03/01/2028

Load more All clinical trials loaded.

HER2-specific CAR T Cell Locoregional Immunotherapy for HER2-positive Recurrent/Refractory Pediatric CNS Tumors

Simultaneous Multinuclear Metabolic MRI in Newly Diagnosed or Recurrent Glioma

Superselective Intra-arterial Cerebral Infusion of Temsirolimus in HGG

Abemaciclib Neuropharmacokinetics of Diffuse Midline Glioma Using Intratumoral Microdialysis

Hypofractionation Trial of Re-irradiation in Good Prognosis Recurrent Glioblastoma

A Study Comparing Abemaciclib Plus Temozolomide to Temozolomide Monotherapy in Children and Young Adults With High-grade Glioma Following Radiotherapy

Cognitive Changes of IDH-mutant and IDH-wildtype Glioma Patients After Chemoradiotherapy With Radiation Dose to the Resting State Networks

Engineered HSV-1 M032 for the Treatment of Children and Adults With Newly Diagnosed Diffuse Midline Glioma After Standard of Care Radiation

Methimazole in Patients With Progressive Glioblastoma

Evaluation of Hippocampal-Avoidance Using Proton Therapy in Low-Grade Glioma

A Study to Learn About the Study Medicine Called PF-07799544 as Monotherapy or in Combination in People With Advanced Solid Tumors

Development of MRF for Characterization of Brain Tumors After Radiotherapy

Step Count Monitoring as a Measure of Physical Activity in Patients With Newly Diagnosed Glioma Undergoing Radiation Therapy

LITT Followed by Hypofractionated RT for Newly Diagnosed Gliomas (GCC 20138)

PrOton Pulsed reduCed dOse Rate Radiotherapy for Recurrent CNS maligNancies Trial

Feasibility of Intraoperative Microdialysis During Neurosurgery for Central Nervous System Malignancies

A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations.

Simulation-Based Caregiving Skills Training for Family Members of High Grade Glioma Patients

Tumor Treating Fields for the Treatment of Brainstem Gliomas

Safusidenib Phase 2 Study in IDH1 Mutant Glioma

Follow us on social media:

Participants

Organizations

Products

About Us

Mobile Apps

Get new clinical trials sent to you?

Paid Clinical Trials for Glioma

Filter Results:

Follow us on social media:

Participants

Organizations

Products

About Us

Mobile Apps